Please use this identifier to cite or link to this item:
Title: Antimicrobial allergy 'labels' drive inappropriate antimicrobial prescribing: lessons for stewardship
Austin Authors: Trubiano, Jason A ;Chen, C;Cheng, AC;Grayson, Lindsay;Slavin, Monica A;Thursky, KA
Affiliation: Department of Infectious Diseases, Austin Health
NHMRC National Centre of Antimicrobial Stewardship, Peter Doherty Institute
Department of Epidemiology & Infectious Diseases, Alfred Health and Monash University
Department of Infectious Diseases, Austin Health,
Department of Infectious Diseases, Peter MacCallum Cancer Centre
Issue Date: 2016 2016-02-18
Publication information: The Journal of Antimicrobial Chemotherapy 2016, epub 18 Feb
Abstract: BACKGROUND: The presence of antimicrobial allergy designations ('labels') often substantially reduces prescribing options for affected patients, but the frequency, accuracy and impacts of such labels are unknown. METHODS: The National Antimicrobial Prescribing Survey (NAPS) is an annual de-identified point prevalence audit of Australian inpatient antimicrobial prescribing using standardized definitions of guideline compliance, appropriateness and indications. Data were extracted for 2 years (2013-14) and compared for patients with an antimicrobial allergy label (AAL) and with no AAL (NAAL). RESULTS: Among 21 031 patients receiving antimicrobials (33 421 prescriptions), an AAL was recorded in 18%, with inappropriate antimicrobial use significantly higher in the AAL group versus the NAAL group (OR 1.12, 95% CI 1.05-1.22, P < 0.002). Patterns of antimicrobial use were significantly influenced by AAL, with lower β-lactam use (AAL versus NAAL; OR 0.47, 95% CI 0.43-0.50, P < 0.001) and higher quinolone (OR 2.07, 95% CI 1.83-2.34, P < 0.0001), glycopeptide (OR 1.59, 95% CI 1.38-1.83, P < 0.0001) and carbapenem (OR 1.74, 95% CI 1.43-2.13, P < 0.0001) use. In particular, among immunocompromised patients, AAL was associated with increased rates of inappropriate antimicrobial use (OR 1.68, 95% CI 1.21-2.30, P = 0.003), as well as increased use of quinolones (OR 1.88, 95% CI 1.16-3.03, P = 0.02) and glycopeptides (OR 1.82, 95% CI 1.17-2.84, P = 0.01). CONCLUSIONS: AALs are common and appear to be associated with higher rates of inappropriate prescribing and increased use of broad-spectrum antimicrobials. Improved accuracy in defining AALs is likely to be important for effective antimicrobial stewardship (AMS), with efforts to 'de-label' inappropriate AAL patients a worthwhile feature of future AMS initiatives.
PubMed URL:
Type: Journal Article
Subjects: Inappropriate Prescribing
Anti-Infective Agents
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.